eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | cutaneous t cell lymphoma |
| Comorbidity | C0026764|myeloma |
| Sentences | 1 |
| PubMedID- 22594538 | The most common dose limiting side-effects with bortezomib are myelosuppression (neutropenia and thrombocytopenia) and sensory neuropathy that occurred in 30-40% patients with myeloma and 50% of patients with ctcl treated with bortezomib. |
Page: 1